Gene · 4287
Papers3,790
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,790
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The deubiquitinating enzyme ATXN3 promotes hepatocellular carcinoma progression by stabilizing TAZ. | Cancer Gene Ther | 2025 | 39672915 | PubTator, text mining | PubMed |
| Mutation Screening of ATXN1, ATXN2, and ATXN3 in Amyotrophic Lateral Sclerosis. | Mol Neurobiol | 2025 | 39496878 | PubTator, text mining | PubMed |
| Investigation of Spinocerebellar Ataxia (SCA) Disease in Iranian Patients and Accurate Trinucleotide Repeat Detection in the SCA3 by TP-PCR Method. | Mol Neurobiol | 2025 | 39155322 | PubTator, text mining | PubMed |
| Biochemical analysis to study wild-type and polyglutamine-expanded ATXN3 species. | PLoS One | 2024 | 39715253 | PubTator, text mining | PubMed |
| Regional distribution of polymorphisms associated to the disease-causing gene of spinocerebellar ataxia type 3. | J Neurol | 2024 | 39666145 | PubTator, text mining | PubMed |
| Generation of induced pluripotent stem cell line (ZZUi037-A) from a patient with spinocerebellar ataxia type 3. | Stem Cell Res | 2024 | 39603094 | PubTator, text mining | PubMed |
| Evolutionary model of repeat insertions in Ataxin-3 traces the origin of the polyglutamine stretch to an ancestral ubiquitin binding module. | Protein Sci | 2024 | 39589068 | PubTator, text mining | PubMed |
| Screening for SCA27B, CANVAS and other repeat expansion disorders in Greek patients with late-onset cerebellar ataxia suggests a need to update current diagnostic algorithms. | J Neurol Sci | 2024 | 39571249 | PubTator, text mining | PubMed |
| Genetic association of missense (rs2919643), intergenic (rs2057178) and a 3'UTR (rs1009170) variant with tuberculosis: A replication study from India. | Infect Genet Evol | 2024 | 39547490 | PubTator, text mining | PubMed |
| Split hand and minipolymyoclonus in spinocerebellar ataxia type 3: a case report. | BMC Neurol | 2024 | 39516744 | PubTator, text mining | PubMed |
| Astragaloside IV reduces mutant Ataxin-3 levels and supports mitochondrial function in Spinocerebellar Ataxia Type 3. | Sci Rep | 2024 | 39472629 | PubTator, text mining | PubMed |
| Identification and Copy Number Variant Analysis of Enhancer Regions of Genes Causing Spinocerebellar Ataxia. | Int J Mol Sci | 2024 | 39456985 | PubTator, text mining | PubMed |
| Small Molecules Inducing Autophagic Degradation of Expanded Polyglutamine Protein through Interaction with Both Mutant ATXN3 and LC3. | Int J Mol Sci | 2024 | 39409036 | PubTator, text mining | PubMed |
| Common pitfalls in drug target Mendelian randomization and how to avoid them. | BMC Med | 2024 | 39407214 | PubTator, text mining | PubMed |
| Age-dependent somatic expansion of the ATXN3 CAG repeat in the blood and buccal swab DNA of individuals with spinocerebellar ataxia type 3/Machado-Joseph disease. | Hum Genet | 2024 | 39375222 | PubTator, text mining | PubMed |
| Deubiquitinases in skeletal muscle-the underappreciated side of the ubiquitination coin. | Am J Physiol Cell Physiol | 2024 | 39344415 | PubTator, text mining | PubMed |
| ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3. | Expert Rev Mol Med | 2024 | 39320846 | PubTator, text mining | PubMed |
| Spinocerebellar Ataxia in Brazil: A Comprehensive Genotype - Phenotype Analysis. | Cerebellum | 2024 | 39317855 | PubTator, text mining | PubMed |
| Thermal Facial Profile and Orofacial Myofunctional Aspects in Movement Disorder Patients: Comparison Between Parkinson Disease and Spinocerebellar Ataxia Type 3. | J Oral Rehabil | 2024 | 39305028 | PubTator, text mining | PubMed |
| Fructose-2,6-bisphosphate restores DNA repair activity of PNKP and ameliorates neurodegenerative symptoms in Huntington's disease. | Proc Natl Acad Sci U S A | 2024 | 39298485 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4287/papers?page=8